Targeting immunosuppressive chemokines for enhanced response to radiotherapy in squamous cell cancers

在加拿大，每年估计有5,000名加拿大人被诊断患有头颈部鳞状细胞癌，另有5,800名患者被诊断患有肺鳞状细胞癌（SCC）。目前患者的治疗选择有限，

In Canada, an estimated 5,000 Canadians are diagnosed with head and neck squamous carcinoma and an additional 5,800 patients are diagnosed with lung squamous cell carcinoma (SCC) on an annual basis. There are currently limited treatment options for patien